Literature DB >> 15082003

Gender, racial and age differences in bladder cancer incidence and mortality.

Ralph Madeb1, Edward M Messing.   

Abstract

Bladder cancer is the fourth most commonly diagnosed cancer in men and the eighth most common in women in the United States. While clinicians who diagnose and treat the disease recognize that bladder cancer has a unique demographic profile, the influence of such factors as age, gender and race on incidence, prognosis, and survival of patients is poorly understood, and has not been the subject of intense investigation. Both through analysis of the population-based databases of bladder cancer in the United States and Europe, as well as epidemiological studies, some of the effects of gender, race and age on this disease have begun to be explained. In this manuscript we review the current literature and epidemiological studies on the affects of gender, race and age on incidence and mortality of bladder cancer.

Entities:  

Mesh:

Year:  2004        PMID: 15082003     DOI: 10.1016/S1078-1439(03)00139-X

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  56 in total

1.  Clinical observation on 2 micron laser for non-muscle-invasive bladder tumor treatment: single-center experience.

Authors:  Chen Zhong; Sanwei Guo; Yueqing Tang; Shujie Xia
Journal:  World J Urol       Date:  2010-03-20       Impact factor: 4.226

2.  The Influence of Race on Overall Survival in Patients with Newly Diagnosed Bladder Cancer.

Authors:  Casey DeDeugd; Makito Miyake; Diego Aguilar Palacios; Charles J Rosser
Journal:  J Racial Ethn Health Disparities       Date:  2014-09-11

Review 3.  Chemoprevention of bladder cancer.

Authors:  Dragan J Golijanin; David Kakiashvili; Ralph R Madeb; Edward M Messing; Seth P Lerner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

4.  Overall and recurrence-free survival among black and white bladder cancer patients in an equal-access health system.

Authors:  Jill K Schinkel; Stephanie Shao; Shelia H Zahm; Katherine A McGlynn; Craig D Shriver; Kangmin Zhu
Journal:  Cancer Epidemiol       Date:  2016-05-06       Impact factor: 2.984

Review 5.  Contemporary gender-specific outcomes in Germany after radical cystectomy for bladder cancer.

Authors:  Marianne Schmid; Shahrokh F Shariat; Armin Soave; Oliver Engel; Margit Fisch; Michael Rink
Journal:  Curr Urol Rep       Date:  2014-06       Impact factor: 3.092

6.  Influence of age on false positive rates of urine-based tumor markers.

Authors:  M Horstmann; T Todenhöfer; J Hennenlotter; S Aufderklamm; J Mischinger; U Kuehs; G Gakis; A Stenzl; C Schwentner
Journal:  World J Urol       Date:  2012-07-18       Impact factor: 4.226

7.  Who should be included in a clinical trial of screening for bladder cancer?: a decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Authors:  Andrew J Vickers; Caroline Bennette; Adam S Kibel; Amanda Black; Grant Izmirlian; Andrew J Stephenson; Bernard Bochner
Journal:  Cancer       Date:  2012-06-26       Impact factor: 6.860

8.  Comparison of CYP1A2 and NAT2 phenotypes between black and white smokers.

Authors:  Joshua E Muscat; Brian Pittman; Wayne Kleinman; Philip Lazarus; Steven D Stellman; John P Richie
Journal:  Biochem Pharmacol       Date:  2008-07-25       Impact factor: 5.858

9.  Treatment of nonmuscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors.

Authors:  Ralph Madeb; Dragan Golijanin; Katia Noyes; Susan Fisher; Judith J Stephenson; Stacey R Long; Joy Knopf; Gary H Lyman; Edward M Messing
Journal:  Cancer       Date:  2009-06-15       Impact factor: 6.860

10.  Impact of age and gender on the clinicopathological characteristics of bladder cancer.

Authors:  Parag Gupta; Manoj Jain; Rakesh Kapoor; K Muruganandham; Aneesh Srivastava; Anil Mandhani
Journal:  Indian J Urol       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.